"He did so voluntarily," the agency said.
With Vioxx, researchers had been warning about the drug's possible cardiovascular risks since 2000, only a year after it was approved by the FDA.
``That's the tragedy here.''
``I was stunned,'' said Kim who had expected positive results.
Yet Merck continued advertising.
``I thought the risk was going to be larger than it was,'' he said.
I couldn't see Merck saying we're going to market a drug with a safety problem.''
``This morning Merck is announcing a voluntary worldwide withdrawal of Vioxx,'' Gilmartin began.
The FDA's own study of the Vioxx safety issue has become mired in controversy.
